What we promise?
Close []
Atosiban
Product Information
| Product | Atosiban |
|---|---|
| CAT No. | CS-O-00863 |
| CAS No. | 90779-69-4 |
| Status | Available for Dispatch by 27-Sep-2023 |
| Category | API Standards, Polypeptide |
| Mol. Wt. | 994.20 mol/g |
| Mol. For. | C₄₃H₆₇N₁₁O₁₂S₂ |
| Hazardous | This is a Hazardous Compound |
Additional Information
| Packing | Product will be supplied in Vials, in certain conditions we also use 'Septa Vials' |
|---|---|
| Controlled | No |
| Parent API | Atosiban |
| Purity | Not less than 95% |
| Therapeutic | Synthetic Peptides |
| Smileys | O=C([C@H](CSSCCC(N[C@@H](C1=O)CC2=CC=C(OCC)C=C2)=O)NC([C@@H](NC([C@](NC(C(N1)[C@@H](C)CC)=O)([H])[C@H](O)C)=O)CC(N)=O)=O)N(CCC3)[C@@H]3C(N[C@@H](CCCN)C(NCC(N)=O)=O)=O |
| Canonical Smiles | CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(=O)N)CC(=O)N)C(C)O |
| InchIKey | VWXRQYYUEIYXCZ-OBIMUBPZSA-N |
| Inchl | InChI=1S/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,55H,5-10,15-22,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,59)(H,48,58)(H,49,62)(H,50,64)(H,51,60)(H,52,61)(H,53,63)/t23-,24+,27-,28+,29-,30-,31-,35-,36-/m0/s1 |
| IUPAC | (2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide |
| Hazardous | Yes |
Safety & Handling Information
| General Information | Use proper personal protective equipment |
|---|---|
| Handling | Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. |
| Engineering Control | Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels. |
| Clothing | Wear appropriate protective clothing to minimize contact with skin. |
| Skin | Wear appropriate protective gloves and clothing to prevent skin exposure. |
| Eyes | Wear safety glasses and chemical goggles if splashing is possible. |
| Inhalation | Remove from exposure and move to fresh air immediately. |
- 30-Days Money Back
- Complete Documentation
- Worldwide Delivery
- Product Accuracy
Sample Label
|
|
Atosiban | www.clearsynth.com |
| CAT : CS-O-00863 | BATCH : CSC-WWW0757 |
|
|
|
|
MF: C₄₃H₆₇N₁₁O₁₂S₂ CAS: 90779-69-4 Date of Anaysis: 22-Aug-2023 Retest Date: 22-Jun-2026 |
MW: 994.20
Store at refrigerator (2-8C) |
Qty: 60 MG |
| Only for R & D and Analytical purpose, Not for Human Consumption. | ||
Sample Packaging
Sample Vials
Product List
Related Products
Atosiban Acetate
API Standards
Need a Quote?
Your email address will not be published. Required fields are marked *